EVIDENCE SYNTHESIS FOR GLOBAL HEALTH: ANIMAL STUDIES UNDER THE LENS

Size: px
Start display at page:

Download "EVIDENCE SYNTHESIS FOR GLOBAL HEALTH: ANIMAL STUDIES UNDER THE LENS"

Transcription

1 EVIDENCE SYNTHESIS FOR GLOBAL HEALTH: ANIMAL STUDIES UNDER THE LENS Paul Garner On behalf of the Cochrane infectious Diseases Group Editors And the Effective Health Care Research Programme Consortium

2 Competing interests Funded by the UK Aid Programme to increase the number of decisions based on reliable evidence in health for the poor in developing countries

3

4

5 previously UK Aid policies were well meaning, but based on expert opinion Example from the British Colonial Service for the Punjab

6

7

8

9

10 1993

11 Systematic reviews 1. Responses from our stakeholders over 20 yr. 2. Findings from a ASR of a new TB vaccine 3. Personal reflections on the agenda

12 Funders Synthesis Researchers Policy maker

13 Stakeholders Our funders

14 Research governance framework for health and social care (2001)

15

16 Global policy makers guidelines panels/advocates Category 1. Those that are happy

17 Amodiaquine (Lancet 1996) 50 studies Better than chloroquine WH O reintroduced in Africa 1998 Impregnated mosquito nets for malaria (Cochrane 1997) Low osmolarity ORS (BMJ/Cochrane 2001) 14 studies Reduced child mortality Helped underpin investment studies Better Changed formula 2003 Artemisinin combination Rx (Lancet 2004) 30 studies 70% increase in cure ACTs first line 2007 Artesunate severe malaria (Cochrane 2007) 8 studies 40% fewer deaths WHO rec 2008

18 Global policy makers guidelines panels/advocates Category 2. Those that are cross

19 Direct observation for TB (BMJ/Cochrane 1997) Deworming for schoolchildren (Cochrane 1996/2011) Primaquine single dose to block transmission (Cochrane 2012/4) 5 studies No difference Controversy Modified early studies Exaggerated claims Investment continued until recently 15 studies Inadequate data Policy remains; research continues

20 Belief disconfirmation bias Belief-confirming evidence: Belief-disconfirming evidence: taken at face value intense critical evaluation

21 Belief disconfirmation bias Standard responses: Original research methods is flawed Synthesis cannot be used here Data incomplete-studies missed You have applied the methods wrongly Synthesis authors are uninformed/ incompetent/trouble makers

22 Cochrane review Does routine deworming improve children s health, performance at school and contribute to economic development?

23

24

25

26

27

28 Deworming review: accountability in question One trial of 22,000 children in 60 clusters showed increased weight gain because it did not adjust for clustering A trial from Vietnam of over 300 children that looked at school performance has never been published One trial of 2 million children remained unpublished 6 years after recruitment ended Re-analysis of Miguel and Kremer study (Nov 2014) the claimed externality effects vanished & no effect on nutrition Plus one more

29 Increasingly Academic competing interests causes substantive biases and distortion Academic behaviour often challenges the principles of scientific integrity

30

31 Systematic review of prime boost TB vaccine Rufaro Kashangura, Emily S. Sena, Taryn Young, Paul Garner

32 Protocol driven study Comparison: vaccine + BCG vs. BCG Animals: any Design: TB challenge given Outcomes: Mortality/euthanasia, pathology in lungs, and bacterial loads in lung

33 Methods Comprehensive search Double application of inclusion criteria Study quality assessed Cumulative meta-analysis

34

35 quality

36 Criteria Were sample size and power calculations given? Was the number of animals clear? Was competing interest declared? Was there randomisation? Was there baseline comparability? Was the outcome assessor blind? Humane endpoint Pathology Bacteriol Williams Williams Goonetille Romano Tchilian Verrick Vorderme Sharpe 2005 (a) 2005 (b) ke ier No No No No No No No No Yes Yes No Yes No Yes Yes Yes No COI statement Not reported All g female pigs Not reported Not reported but objective Not reported No COI statement Not reported Same species pigs Not reported No COI statement Not reported All 8-10wk old female mice. Not reported No COI statement Not reported All 8-10 weeks old mice. Not reported No COI statement Not reported All 6-8wk old female mice. Not reported Contains COI with conflict Yes Same age weight, male macaques. Not reported Contains COI with conflict Not Reported All six month old cattle. No COI statemen t Not reported All 4 yr old macaque s. Not reported Yes Yes Only lesion volume blinded Not reported Not reported Not reported

37 Outcomes

38 Bacterial load

39 Pathology summary Authors conclusion Our interpretation William 2005 Guinea pigs Not able to discriminate No data provided (b) 14 William 2005 (b) 14 Guinea pigs Not significantly better than BCG No data provided Verrick 2009 c 18 Macaques BCG/MVA85A less severe disease and fewer lesions than BCG only Vordermeier Calves Sharpe Macaques significantly reduced after MVA85A vaccination compared to control f No statistical difference between MVA85A vaccinated and BCG vaccinated animals for lesions in lung, lung pathology and gross pathology scoring Scores in both BCG alone and MVA85A boost much lower than controls No direct statistical comparison between MVA85A and BCG. No statistical difference but more lesions in BCG and MVA85A groups. Other parameters show no trends

40 Mortality

41

42 Implications for strategy We as a group have a duty to develop the science and reviews in this area It has to be independent of the researchers The so called scientists will be sceptical (watch for belief disconfirmation bias ) We have to get FUNDERS and the PUBLIC onside

Global progress in vaccine development

Global progress in vaccine development Global progress in vaccine development Helen McShane The Jenner Institute University of Oxford helen.mcshane@ndm.ox.ac.uk Vaccination The most cost-effective health intervention Smallpox Poliomyelitis

More information

Vector control and policy: systematic reviews

Vector control and policy: systematic reviews Vector control and policy: systematic reviews Funding source I am funded by UKAid to increase decisions based on reliable evidence in health in LMIC I am responsible for the WHO Collaborating Centre for

More information

Instrument for the assessment of systematic reviews and meta-analysis

Instrument for the assessment of systematic reviews and meta-analysis Appendix II Annex II Instruments for the assessment of evidence As detailed in the main body of the methodological appendix (Appendix II, "Description of the methodology utilised for the collection, assessment

More information

Can we afford DAA for all???

Can we afford DAA for all??? The 4P Group Public Health Community Physicians and scientists Policy makers Pharmaceutical companies Can we afford DAA for all??? Maud Lemoine Imperial College London MRC, the Gambia Unit, West Africa

More information

Estimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana

Estimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana Estimating TB burden Philippe Glaziou World Health Organization Accra, Ghana Outline Basic facts about TB epidemiology What should we expect with regards TB burden over time? Main indicators of TB disease

More information

Update on TB Vaccines

Update on TB Vaccines Update on TB Vaccines Hennie Geldenhuys 11 May 2012 A safe and effective TB Vaccine within a decade A Strategic Blueprint for the Next Decade Tuberculosis, Vol 92, March 2012, Suppl. 1, pgs S1-S35 On

More information

UNICEF AND MALARIA MEDICINES. Supply Division October 2006

UNICEF AND MALARIA MEDICINES. Supply Division October 2006 UNICEF AND MALARIA MEDICINES Supply Division October 2006 PROCUREMENT SERVICES SUPPORTING CHILD RIGHTS UNICEF PROVIDES PROCUREMENT SERVICES AS PART OF ITS MANDATE Helping partners access resources for

More information

Alcohol interventions in secondary and further education

Alcohol interventions in secondary and further education National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods

More information

How to optimise immunisation: a live vaccine last policy. Frank Shann University of Melbourne

How to optimise immunisation: a live vaccine last policy. Frank Shann University of Melbourne How to optimise immunisation: a live vaccine last policy Frank Shann University of Melbourne We can no longer assume that a vaccine: 1. Acts independently of other vaccines 2. Influences only infections

More information

Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries

Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries Briefing Document: National decision-making framework for malaria vaccines Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries This is one of seven briefing

More information

RARE-Bestpractices Conference

RARE-Bestpractices Conference RARE-Bestpractices Conference 24 November 2016, Istituto Superiore di Sanità, Rome, Italy Avoiding waste in production, design and conduct of studies and reporting evidence on rare diseases Philippe Ravaud

More information

Critical Thinking A tour through the science of neuroscience

Critical Thinking A tour through the science of neuroscience Critical Thinking A tour through the science of neuroscience NEBM 10032/5 Publication Bias Emily S Sena Centre for Clinical Brain Sciences, University of Edinburgh slides at @CAMARADES_ Bias Biases in

More information

Chemoprophylaxis and intermittent treatment for preventing malaria in children (Review)

Chemoprophylaxis and intermittent treatment for preventing malaria in children (Review) Chemoprophylaxis and intermittent treatment for preventing malaria in children (Review) Meremikwu MM, Donegan S, Esu E This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration

More information

The human immunodeficiency virus/acquired immune

The human immunodeficiency virus/acquired immune Vol. 7(4), pp. 44-48, May 2015 DOI: 10.5897/JAHR2014.0320 Article Number: 70F676253212 ISSN 2141-2359 Copyright 2015 Author(s) retain the copyright of this article http://www.academicjournals.org/jahr

More information

GRADE tables to assist guideline development and recommendations. Plain Language Summary of Results

GRADE tables to assist guideline development and recommendations. Plain Language Summary of Results Seasonal Malaria Chemoprevention (formally known as Intermittent Preventive Treatment in children) for preventing malaria morbidity in children aged less than 5 years living in areas of marked seasonal

More information

Copenhagen, Denmark, September August Malaria

Copenhagen, Denmark, September August Malaria Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support

More information

Against intervention No recommendation Strong Conditional Conditional Strong. For intervention. High Moderate Low Very low

Against intervention No recommendation Strong Conditional Conditional Strong. For intervention. High Moderate Low Very low Draft recommendation: Consider using MDA as an additional tool for the elimination of malaria in low prevalence island or nonisland settings where the risk of imported malaria is low Balance of desirable

More information

Why published medical research may not be good for your health

Why published medical research may not be good for your health Why published medical research may not be good for your health Doug Altman EQUATOR Network and Centre for Statistics in Medicine University of Oxford 2 Reliable evidence Clinical practice and public health

More information

WG: Vaccinations and child survival Focus:

WG: Vaccinations and child survival Focus: WG: Vaccinations and child survival Focus: Monitoring childhood interventions including routine services and campaigns => To find possible changes in policy Why is that necessary? Paradox: All interventions

More information

Antimicrobial resistance Fact sheet N 194 Updated April 2014

Antimicrobial resistance Fact sheet N 194 Updated April 2014 Antimicrobial resistance Fact sheet N 194 Updated April 2014 Key facts Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by

More information

TB Vaccine Research and Development: Progress, Strategies and Controversies

TB Vaccine Research and Development: Progress, Strategies and Controversies 15 March 2016 GVIRF Global Forum Johannesburg, South Africa TB Vaccine Research and Development: Progress, Strategies and Controversies Lewis Schrager, M.D. V.P., Scientific Affairs Rockville, MD USA Source:

More information

Malaria. Edwin J. Asturias, MD

Malaria. Edwin J. Asturias, MD Malaria Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public Health Global Health and Disasters Course

More information

Behaviour Change: Supporting interventions for introduction of malaria RDTs in Cameroon & Nigeria

Behaviour Change: Supporting interventions for introduction of malaria RDTs in Cameroon & Nigeria Behaviour Change: Supporting interventions for introduction of malaria RDTs in Cameroon & Nigeria ACT Consortium LSHTM: Virginia Wiseman, Lindsay Mangham-Jefferies, Bonnie Cundill, Clare Chandler, Neal

More information

38 Current Concepts in

38 Current Concepts in 38 Current Concepts in Management of Falciparum Malaria Abstract: Artemisinin based Combination Therapy (ACT) is the preferred agent to treat drug resistance uncomplicated Plasmodium Falciparum (PF) Malaria.

More information

CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews

CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews Since September 2013, the CEU has been responsible for pre-publication screening of new intervention

More information

THE Price of a Pandemic 2017

THE Price of a Pandemic 2017 THE Price of a Pandemic 2017 From 2000-2015: 33 million people died because of TB at a global economic cost of $617bn This report was produced the Global TB Caucus, an international network of over 2,000

More information

School of Dentistry. What is a systematic review?

School of Dentistry. What is a systematic review? School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical

More information

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR) DATABASE Cochrane Database of Systematic Reviews DATE 15 DECEMBER 2015 #1 Safety of Crucell Ad35/ AERAS-402 OR Effectiveness of Crucell Ad35/ Aeras-402 OR Safety of MVA85A/ Aeras-485 OR Effectiveness of

More information

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and

More information

Gambling attitudes and misconceptions

Gambling attitudes and misconceptions FINDINGS The results have been presented showing the effect sizes of interventions. When heterogeneity was absent the studies were pooled. However, the confidence intervals should be considered with caution.

More information

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Part I: Evaluation of the current list Proposed grouping from the March 2007 meeting 6.5.3 Antimalarial medicines 6.5.3.1 For curative

More information

Improving Return on Public Health Investments in Disasters with Evidence Synthesis

Improving Return on Public Health Investments in Disasters with Evidence Synthesis Improving Return on Public Health Investments in Disasters with Evidence Synthesis Karen A. Robinson Johns Hopkins University Evidence Aid 17 Nov 2016 Evidence Synthesis Formal methods for summarizing

More information

Disclosure Information

Disclosure Information Malaria Medications Charlie Mosler, RPh, PharmD, CGP, FASCP Assistant Professor of Pharmacy Practice The University of Findlay College of Pharmacy Findlay, OH mosler@findlay.edu Disclosure Information

More information

Implementing the Abuja Declaration and Plan of Action: the journey so far

Implementing the Abuja Declaration and Plan of Action: the journey so far Implementing the Abuja Declaration and Plan of Action: the journey so far The Abuja Declaration African leaders who met on 25 April 2000 in Abuja, Nigeria, laid out the foundation for a sustained battle

More information

The potential public health impact of new TB vaccines

The potential public health impact of new TB vaccines The potential public health impact of new TB vaccines 5 th Global Forum on TB Vaccines Richard White 1,2, Rebecca Harris 2, Chathika Weerasuriya 2 1 TB Modelling and Analysis Consortium 2 TB Modelling

More information

A New Class of Malaria Drugs: The Coartem Breakthrough from Novartis

A New Class of Malaria Drugs: The Coartem Breakthrough from Novartis A New Class of Malaria Drugs: The Coartem Breakthrough from Novartis and its Chinese Partners Hans Rietveld, Director, Global Access and Marketing, Malaria Initiative, Novartis Pharma AG Workshop on Access

More information

HOW EFFECTIVE ARE ANTIVIRAL DRUGS AGAINST INFLUENZA? Dr Puja Myles

HOW EFFECTIVE ARE ANTIVIRAL DRUGS AGAINST INFLUENZA? Dr Puja Myles HOW EFFECTIVE ARE ANTIVIRAL DRUGS AGAINST INFLUENZA? Dr Puja Myles Puja.myles@nottingham.ac.uk ANTIVIRALS CURRENTLY USED IN INFLUENZA Previously, M2-inhibitors (amantadine and rimantadine) From 1999, Neuraminidase

More information

Factors affecting child development in developing countries

Factors affecting child development in developing countries Factors affecting child development in developing countries S Grantham-McGregor Centre for Health and Development, Institute of Child Health, University College London Figure 1.1 The Lancet series: The

More information

Accelerating progress towards the health-related Millennium Development Goals

Accelerating progress towards the health-related Millennium Development Goals Accelerating progress towards the health-related Millennium Development Goals The critical role of the national health policy & strategy in strengthening health systems and delivering effective interventions

More information

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 1. INTRODUCTION The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 2014 2018 UNITE AGAINST DIABETES STOP RISING TREND Diabetes is a significant and growing challenge globally that affects individuals,

More information

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director Global health and vaccination: TB & beyond Dr Mary Moran Executive Director mmoran@policycures.org Outline About Policy Cures 3 reasons to focus on vaccine innovation Where are we today? The pipeline Where

More information

Novartis: tackling adherence. ESPACOMP, September, 2010

Novartis: tackling adherence. ESPACOMP, September, 2010 Novartis: tackling adherence ESPACOMP, September, 2010 Novartis is a world-leading healthcare company Leading market position One of 20 largest companies by market capitalization Among most respected companies

More information

Crude health statistics

Crude health statistics Crude health statistics Crude health stats are measurements of indicators that come directly from primary data collection with no adjustment or corrections Drawbacks Incomplete ascertainment Non representativeness

More information

ART for prevention the task ahead

ART for prevention the task ahead ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

Tanzania s Progress in Combating Malaria: Achievement and Challenges

Tanzania s Progress in Combating Malaria: Achievement and Challenges Tanzania s Progress in Combating Malaria: Achievement and Challenges DR RENATA A MANDIKE DEPUTY PROGRAMME MANAGER NATIONAL MALARIA CONTROL PROGRAMME, MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER,

More information

Journal Assignment #2. Malaria Epidemics throughout the World

Journal Assignment #2. Malaria Epidemics throughout the World Journal Assignment #2 Malaria Epidemics throughout the World In this assignment, you will study malaria and how it has impacted several world regions and how its global impact has had devastating effects

More information

If I m interested, why is it a conflict? Ross McKinney, Jr, MD

If I m interested, why is it a conflict? Ross McKinney, Jr, MD If I m interested, why is it a conflict? Ross McKinney, Jr, MD Overview Define Conflicts of Interest Consider the effects of COI on research Propose that bias and non-reproducibility are larger problems

More information

Combination Anti-malarial Therapy and WHO Recommendations

Combination Anti-malarial Therapy and WHO Recommendations Prakaykaew Charunwatthana 2, and Sasithon Pukrittayakamee 1,2 1 Associate Fellow of the Royal Institute, Academy of Science 2 Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol

More information

Developing Logic Models

Developing Logic Models Developing Logic Models Developing Logic Models 2 An introduction to using Logic Models in CIDG reviews. What are Logic Models? Logic models are diagrams which map out important concepts within a systematic

More information

Monitoring tuberculosis progression using MRI and stereology

Monitoring tuberculosis progression using MRI and stereology Monitoring tuberculosis progression using MRI and stereology TB the problem Estimated number of new cases in 2007 2 million deaths; 9 million new cases p.a. TB kills someone every 15 secs, 9,153 cases

More information

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people

More information

Suraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable

Suraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,

More information

Monitoring of the achievement of the health-related Millennium Development Goals

Monitoring of the achievement of the health-related Millennium Development Goals SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered

More information

Washington, DC, November 9, 2009 Institute of Medicine

Washington, DC, November 9, 2009 Institute of Medicine Holger Schünemann, MD, PhD Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada Washington, DC, November 9, 2009 Institute

More information

RATING OF A RESEARCH PAPER. By: Neti Juniarti, S.Kp., M.Kes., MNurs

RATING OF A RESEARCH PAPER. By: Neti Juniarti, S.Kp., M.Kes., MNurs RATING OF A RESEARCH PAPER RANDOMISED CONTROLLED TRIAL TO COMPARE SURGICAL STABILISATION OF THE LUMBAR SPINE WITH AN INTENSIVE REHABILITATION PROGRAMME FOR PATIENTS WITH CHRONIC LOW BACK PAIN: THE MRC

More information

Funding Opportunities for Public Health Research

Funding Opportunities for Public Health Research Funding Opportunities for Public Health Research IPH Open Conference,Titanic Belfast, 11 October 2016 Dr Nicola Armstrong Programme Manager HSC R&D Division, Public Health Agency Outline Strategic Context

More information

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,

More information

What is new. Sandra Caldeira, Joint Research Centre

What is new.  Sandra Caldeira, Joint Research Centre What is new Joint Meeting of the High Level Group on Nutrition and Physical Activity and the EU Platform for Action on Diet, Physical Activity and Health Brussels, 10 June 2014 Sandra Caldeira, Joint Research

More information

Ross Fund Summary January 2016

Ross Fund Summary January 2016 Ross Fund Summary January 2016 Ross Fund The 1 billion Ross Fund was announced by the Chancellor of the Exchequer in November 2015 and will be managed by Department for International Development (DFID)

More information

Understanding vaccine development

Understanding vaccine development Understanding vaccine development Firdausi Qadri Director, Centre for Vaccine Sciences International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Outline of this talk 1. Understanding disease

More information

Update on TB Vaccines. Mark Hatherill South African TB Vaccine Initiative (SATVI) University of Cape Town

Update on TB Vaccines. Mark Hatherill South African TB Vaccine Initiative (SATVI) University of Cape Town Update on TB Vaccines Mark Hatherill South African TB Vaccine Initiative (SATVI) University of Cape Town 1 Robert Koch s Therapeutic TB vaccine 1890: Purified Tuberculin Protein 1891: First negative reports

More information

EQUATOR Network: promises and results of reporting guidelines

EQUATOR Network: promises and results of reporting guidelines EQUATOR Network: promises and results of reporting guidelines Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK Key principles of research publications A published research

More information

Human Health Using nuclear techniques to improve health around the world

Human Health Using nuclear techniques to improve health around the world Human Health Using nuclear techniques to improve health around the world With its wide range of activities and expertise in nuclear science and medicine, the IAEA is helping Member States use nuclear techniques

More information

HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations Population Fund

HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations Population Fund The 2 nd Advanced Vaccinology course (NVCO) DDC, Radisson Bangkok 15 17 June 2010 HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations

More information

The Johns Hopkins Vaccine Initiative Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Vaccine Initiative Johns Hopkins Bloomberg School of Public Health WHO Internships (Terms of Reference) for VIEW Scholars Program January 2010 A. Examining approaches to collecting and analyzing HPV vaccine coverage data B. County level burden of disease estimates for

More information

Cancer research investment should shift from late stage treatment to early stage detection No!

Cancer research investment should shift from late stage treatment to early stage detection No! Cancer research investment should shift from late stage treatment to early stage detection No! KC Soo National Cancer Centre Singapore Duke-NUS Graduate Medical School 3 caveats 1. The primacy of cancer

More information

Ending Malaria in Nigeria: The WHO Agenda

Ending Malaria in Nigeria: The WHO Agenda Nigeria Institute of Medical Research 2016 World Malaria Day Lecture 27 April, 2016 Ending Malaria in Nigeria: The WHO Agenda Dr Tolu Arowolo Malaria Containment Programme, WHO, Nigeria arowolot@who.int

More information

The non-human primate model in TB vaccine development

The non-human primate model in TB vaccine development April 10, 2015 The non-human primate model in TB vaccine development Tom Evans MD Aeras Agenda Issues Transmission studies Recent advancements Outcomes Endpoint analysis Design Going forward 2 Development

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

USDA Nutrition Evidence Library: Systematic Review Methodology

USDA Nutrition Evidence Library: Systematic Review Methodology USDA Nutrition Evidence Library: Systematic Review Methodology Julie E. Obbagy, PhD, RD USDA Center for Nutrition Policy & Promotion Meeting #2 October 17, 2016 The National Academies of Sciences, Engineering,

More information

The growing burden of noncommunicable diseases (NCDs)

The growing burden of noncommunicable diseases (NCDs) The WHO Noncommunicable Diseases Global Surveillance Strategy: Experience in the African Region Burden of noncommunicable diseases The growing burden of noncommunicable diseases (NCDs) represents a major

More information

Mathematical modelling to accelerate development of new tuberculosis vaccines

Mathematical modelling to accelerate development of new tuberculosis vaccines Mathematical modelling to accelerate development of new tuberculosis vaccines Preliminary Results Rebecca Harris, Tom Sumner, Gwen Knight and Richard White 22 nd February 2018 Harris et al. 2016 Modelling

More information

Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018

Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018 Overview of the Malaria Vaccine Implementation Programme (MVIP) Prof. Fred Were SAGE meeting 17 April, 2018 1 Objectives Brief review Background EMA positive opinion and WHO recommendations Funding Description

More information

Determining the size of a vaccine trial

Determining the size of a vaccine trial 17th Advanced Vaccinology Course Annecy 26 th May 2016 Determining the size of a vaccine trial Peter Smith London School of Hygiene & Tropical Medicine Purposes of lecture Introduce concepts of statistical

More information

Avoiding common errors in research reporting:

Avoiding common errors in research reporting: Avoiding common errors in research reporting: Increasing usability (and potential impact) of your research Iveta Simera Outline Common reporting deficiencies in published research Particularly those limiting

More information

Application of human epidemiological studies to pesticide risk assessment

Application of human epidemiological studies to pesticide risk assessment Workshop What does the future hold for harmonised human health risk assessment of plant protection products? Application of human epidemiological studies to pesticide risk assessment Antonio F. Hernández,

More information

Introduction to Experiments

Introduction to Experiments Experimental Methods in the Social Sciences Introduction to Experiments August 5, 2013 Experiments Increasingly Important in the Social Sciences Field experiments in political science as early as 1920s

More information

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

ENDING AIDS, TB AND MALARIA AS EPIDEMICS ENDING AIDS, TB AND MALARIA AS EPIDEMICS A SMART INVESTMENT In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless

More information

Issues in African Economic Development. Economics 172. University of California, Berkeley. Department of Economics. Professor Ted Miguel

Issues in African Economic Development. Economics 172. University of California, Berkeley. Department of Economics. Professor Ted Miguel Economics 172 Issues in African Economic Development Professor Ted Miguel Department of Economics University of California, Berkeley Economics 172 Issues in African Economic Development Lecture 11 February

More information

MALARIA & POVERTY IN AFRICA

MALARIA & POVERTY IN AFRICA MALARIA & POVERTY IN AFRICA Edited by Augustin Kwasi Fosu Germano Mwabu University of NAIROBI Library 1111111" 1111111111111111111111111111111 0370077 0 University of Nairobi Press Table of Contents List

More information

~Health and Development Initiative~

~Health and Development Initiative~ ~Health and Development Initiative~ Global Issues Division International Cooperation Bureau Ministry of Foreign Affairs, Japan March 2007 More than 10 million children

More information

Malaria. Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania

Malaria. Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania Malaria Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania Despite 42% reduction since 2000, a child dies every minute in Africa from malaria 207 million malaria cases in 2012,

More information

Role of vaccination and the evaluation of LSD control programmes

Role of vaccination and the evaluation of LSD control programmes Role of vaccination and the evaluation of LSD control programmes Dr Nick Lyons FAO Workshop: LSD prevention and control Tbilisi, Georgia, 11th November 2015 Vaccines and protection Susceptible Infected

More information

Stakeholder preferred ways to reduce production diseases in broiler chickens and layer hens

Stakeholder preferred ways to reduce production diseases in broiler chickens and layer hens Stakeholder preferred ways to reduce production diseases in broiler chickens and layer hens Philip Jones*, Jarkko Niemi** and Richard Tranter* * Centre for Agricultural Strategy, University of Reading,

More information

BMGF MALARIA STRATEGY TO 2020

BMGF MALARIA STRATEGY TO 2020 BMGF MALARIA STRATEGY TO 2020 Supporting the Drive to Elimination in Mesoamerica & Hispaniola Diana Measham, DrPH, MSc Lead Eliminate Initiative September 25, 2014 The world has three potential future

More information

Investing for a Malaria-Free World

Investing for a Malaria-Free World Investing for a Malaria-Free World Recent years have seen extraordinary advances in the fight against malaria, but the gains are fragile and unevenly distributed. Victory against the malaria parasite would

More information

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework

More information

The Cochrane Collaboration s response to the aftermath of the tsunami

The Cochrane Collaboration s response to the aftermath of the tsunami The Cochrane Collaboration s response to the aftermath of the tsunami Pisake Lumbiganon, MD, MS Professor in Ob & Gyn Thai Cochrane Network Khon Kaen University Khon Kaen, Thailand 13/05/48 Thai Cochrane

More information

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives

More information

Interpretation of the World Malaria Report Country Profile

Interpretation of the World Malaria Report Country Profile Interpretation of the World Malaria Report Country Profile Acknowledgements This presentation was developed to help explain the components of the World Malaria Report Country Profile. The 2017 World Malaria

More information

Monitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition

Monitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD El Salvador The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress

More information

Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group -

Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group - Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group - 8 July 2008 This report is the recommendation from the G8 Health Experts Group to the G8 leaders. I Introduction 1.

More information

Preparedness for candidate HCV vaccine trials in people who inject. C Vaccine Initiative*

Preparedness for candidate HCV vaccine trials in people who inject. C Vaccine Initiative* Preparedness for candidate HCV vaccine trials in people who inject drugs: Challenges and opportunities Li M h b h lf f th UNSW H titi Lisa Maher, on behalf of the UNSW Hepatitis C Vaccine Initiative* Background

More information

UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA

UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA ABUJA CALL FOR ACCELERATED ACTION TOWARDS UNIVERSAL ACCESS TO HIV AND AIDS, TUBERCULOSIS AND MALARIA SERVICES IN AFRICA AFRICAN UNION UNION AFRICAINE UNIÃO

More information

TB vaccine progress. Hassan Mahomed. Institute of Infectious Disease and Molecular Medicine, School of Child and Adolescent Health,

TB vaccine progress. Hassan Mahomed. Institute of Infectious Disease and Molecular Medicine, School of Child and Adolescent Health, TB vaccine progress Hassan Mahomed South African TB Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, School of Child and Adolescent Health, University of Cape Town, South

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

Need for Chronic Viral Hepatitis Monitoring System

Need for Chronic Viral Hepatitis Monitoring System Need for Chronic Viral Hepatitis Monitoring System Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands Rotterdam November 2008 National

More information

Special health needs of women and children

Special health needs of women and children Special health needs of women and children Images used in this presentation are from UNICEF State of the World s Children 2009; and from Wikimedia Commons Julie Byles Women s Health is important to all

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information